The Reserve Bank of India attracted $136 billion through its foreign exchange swap window, raising forex reserves from $681 billion in May to $785.7 billion. The rupee recovered to 94.50 against the US dollar from an all-time low of 96.50.
The real policy problem is not the swap itself—it is what $136 billion converted into rupees does to the banking system. The RBI created a core liquidity surplus of approximately ₹12 trillion, roughly 10 times recent averages. That multiplication through the money supply poses immediate inflation risk in an economy already facing sticky commodity prices and food inflation from monsoon deficits.
The RBI now confronts a modern monetary quadrilemma: it cannot simultaneously maintain free capital flows, defend the rupee, conduct independent policy, and prevent asset inflation from destabilizing the financial system. Each tool it deploys constrains the others.
The central bank has classical sterilization options. Market Stabilization Scheme bonds, cash reserve ratio hikes, and open market operations can drain liquidity. But ₹12 trillion represents uncharted sterilization scale. The swap's direct cost—2.5 to 3 percent per annum after offsetting dollar asset returns—runs roughly ₹25,000 crore annually, a manageable fraction of RBI dividends. The liquidity cost is different.
Bond markets are already pricing rate hike risk. Any RBI move to issue MSS bonds or raise the CRR would immediately compress short-term yields upward and flatten the curve as investors reprice duration risk across longer maturities. A hawkish shift would force a repricing of the entire Indian yield curve and drain demand for duration—exactly the opposite of where fund flows have headed since May.
The RBI's next liquidity report will be watched for signals of sterilization intent. How aggressively it absorbs the surplus will determine whether the swap succeeds as a rupee stabilizer or becomes the catalyst for tighter financial conditions and a rally in short-end yields.
